Drug-Drug Interaction Study Evaluating Effects of ASP015K on Rosuvastatin

NCT01959399 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects
Pharmacokinetics of ASP015K

Interventions

DRUG: ASP015K
DRUG: Rosuvastatin

Sponsor

Astellas Pharma Global Development, Inc.

Collaborators

[object Object]